The EMBL-EBI–AstraZeneca Postdoctoral (EAZPOD) Programme builds on the collaborative relationship between EMBL-EBI and AstraZeneca, offering projects that push the boundaries of cutting-edge computational biology in oncology.

EAZPOD fellows will be awarded salary funding for three years to carry out a research project between a group at EMBL-EBI and Computational Oncology at AstraZeneca. This is an exciting and unique opportunity to combine methodological development and modelling with access to preclinical and clinical multi-omics data to drive forward research for patient benefit.

For more information click here